These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9434752)
1. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity. Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752 [TBL] [Abstract][Full Text] [Related]
2. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver. Chow T; Imaoka S; Hiroi T; Funae Y Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501 [TBL] [Abstract][Full Text] [Related]
3. Catalytic specificity of CYP2D isoforms in rat and human. Hiroi T; Chow T; Imaoka S; Funae Y Drug Metab Dispos; 2002 Sep; 30(9):970-6. PubMed ID: 12167561 [TBL] [Abstract][Full Text] [Related]
4. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study. Bromek E; Haduch A; Daniel WA Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4. Scheller U; Zimmer T; Kärgel E; Schunck WH Arch Biochem Biophys; 1996 Apr; 328(2):245-54. PubMed ID: 8645001 [TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody. Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729 [TBL] [Abstract][Full Text] [Related]
7. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Miyazawa M; Shindo M; Shimada T Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812 [TBL] [Abstract][Full Text] [Related]
9. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes. Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737 [TBL] [Abstract][Full Text] [Related]
10. Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats. Sakai N; Saito K; Kim HS; Kazusaka A; Ishizuka M; Funae Y; Fujita S Drug Metab Dispos; 2005 Nov; 33(11):1657-60. PubMed ID: 16081673 [TBL] [Abstract][Full Text] [Related]
11. Characterization of two P-450 isozymes placed in the rat CYP2D subfamily. Ohishi N; Imaoka S; Suzuki T; Funae Y Biochim Biophys Acta; 1993 Nov; 1158(3):227-36. PubMed ID: 8251521 [TBL] [Abstract][Full Text] [Related]
12. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes. McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831 [TBL] [Abstract][Full Text] [Related]
13. Complementary DNA cloning and characterization of cytochrome P450 2D29 from Japanese monkey liver. Hichiya H; Takemi C; Tsuzuki D; Yamamoto S; Asaoka K; Suzuki S; Satoh T; Shinoda S; Kataoka H; Narimatsu S Biochem Pharmacol; 2002 Oct; 64(7):1101-10. PubMed ID: 12234613 [TBL] [Abstract][Full Text] [Related]
14. The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6. Fukuda T; Nishida Y; Imaoka S; Hiroi T; Naohara M; Funae Y; Azuma J Arch Biochem Biophys; 2000 Aug; 380(2):303-8. PubMed ID: 10933885 [TBL] [Abstract][Full Text] [Related]
15. Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation. Gut J; Gasser R; Dayer P; Kronbach T; Catin T; Meyer UA FEBS Lett; 1984 Aug; 173(2):287-90. PubMed ID: 6146537 [TBL] [Abstract][Full Text] [Related]
16. Complementary DNA cloning, functional expression and characterization of a novel cytochrome P450, CYP2D50, from equine liver. DiMaio Knych HK; Stanley SD Biochem Pharmacol; 2008 Oct; 76(7):904-11. PubMed ID: 18692486 [TBL] [Abstract][Full Text] [Related]
18. The roles of amino acid residues at positions 43 and 45 in microsomal contents and enzymatic functions of rat CYP2D1 and CYP2D2. Narimatsu S; Imoto K; Isobe T; Kiryu K; Naito S; Hichiya H; Funae Y; Hanioka N; Yamamoto S Biochem Biophys Res Commun; 2004 Nov; 324(2):627-33. PubMed ID: 15474473 [TBL] [Abstract][Full Text] [Related]
19. Enzymatic properties of cytochrome P450 catalyzing 3'-hydroxylation of naringenin from the white-rot fungus Phanerochaete chrysosporium. Kasai N; Ikushiro S; Hirosue S; Arisawa A; Ichinose H; Wariishi H; Ohta M; Sakaki T Biochem Biophys Res Commun; 2009 Sep; 387(1):103-8. PubMed ID: 19576179 [TBL] [Abstract][Full Text] [Related]
20. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450. Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]